GlaxoSmithKline has attempted to knock out the plaintiff’s experts in Dolin v. GlaxoSmithKline, in its latest round of Daubert motions. Wendy Dolin is suing GSK after the suicide death of her prominent lawyer husband, who had been taking the generic form of Paxil, paroxetine, an antidepressant. This case made national news just a year ago when Judge Zagel of the Northern District of Illinois held that GSK could be liable for Dolin’s death under a negligence theory, not a product liability theory, even though…
Continue reading...
Litigation
Continue reading...
- Pamlab Can’t Bar Virtus’ Marketing In Unfair Competition Row (subscription required)
- Pa. Appeals Court Upholds GSK Win in Paxil Pregnancy Suit (subscription required)
- J&J Asks Pa. Court to Keep Risperdal Docs Under Seal (subscription required)
- Standing Issue Threatens 15 Zometa Suits in NJ (subscription required)
- 23andMe Hit with False Ad Suit Over DNA Tests (subscription required)
- Diageo Shells Out $81M to Settle Aussie, NZ Thalidomide Suits (subscription required)
- Generic-Reglan Suits Doomed by Catch-22, 6th Circ. Says (subscription required)
- J&J
Continue reading...
Litigation
Continue reading...
- Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide
- Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required)
- Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required)
- Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine
- Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required)
- OxyElite Pro Class Action Filed Over False Advertising
- First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014
- J&J Takes Innovative,
Continue reading...
British drugmaker GlaxoSmithKline (GSK) announced on July 25th that it would pay $229 million to resolve lawsuits brought by eight U.S. states related to improper marketing of its diabetes drug Avandia (rosiglitazone). In a regulatory filing, GSK said the settlement was within provisions it had previously set aside for litigation, and also resolved claims brought by the Attorney General of Louisiana involving other GSK products.
The announcement by GSK explained that the settlements had been undertaken in order to avoid lengthy trials, and did…
Continue reading...
Continue reading...